Glycerin Suppository: Clinical Trials

5 trials of Glycerin Suppository, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting, 1 terminated. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Completed 3, Recruiting 1, Terminated 1

Follow Glycerin Suppository: new trials by email Literature Review of Glycerin Suppository trials Research Report on Glycerin Suppository

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comprehensive Toileting Program
Glycerin Suppository, Behavioral strategies - Encopresis, ASD
Phase 4RecruitingEmory University1502026-06-012026-06-18
Evaluation of Glycerin Suppositories to Improve Bowel Function in Gastroschisis
Glycerin Suppository - Gastroschisis
Phase 4TerminatedIndiana University162017-10-012021-10-12
B&O for TLH Post-operative Pain and Nausea
Belladonna Opium, Glycerin Suppository - Hysterectomy, Pain, Postoperative
Phase 4CompletedAnna Reinert562016-06-012019-04-02
Rectal Indomethacin to Prevent Post ESWL-pancreatitis
indomethacin suppository, Glycerin Suppository - Pancreatitis
Phase 4CompletedChanghai Hospital13702016-05-312022-05-26
Assessing Maternal Post-partum Pain With Suppositories
Belladonna and opioid suppository, Glycerin Suppository - Pain
Phase 4CompletedLoyola University1002009-07-222018-03-07

Conditions studied

Encopresis (1)  ·  Gastroschisis (1)  ·  Pain (1)  ·  Pain, Postoperative (1)  ·  Pancreatitis (1)  ·  Pancreatitis, Chronic (1)

Sponsors

Anna Reinert (1)  ·  Changhai Hospital (1)  ·  Emory University (1)  ·  Indiana University (1)  ·  Loyola University (1)

Countries

United States (4)  ·  China (1)

Top investigators

Alan Ladd, M.D. (1)  ·  Kevin Audlin, MD (1)  ·  Kimberly Kenton, M.D. (1)  ·  Mindy Scheithauer, PhD (1)  ·  Zhuan Liao, MD (1)

Results publications

PMID 29096689, PMID 33078388, PMID 35085482

NIH funding

R01HD115933 (1)